Clinical Trial

Rademikibart IV for Acute Asthma and COPD Exacerbation

Name: Rademikibart IV for Acute Asthma and COPD Exacerbation — clinical trial record (NCT07705737)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A Phase 2, open-label, single-arm trial to evaluate IV rademikibart as an add-on treatment for acute exacerbation in participants with asthma or COPD with type 2 inflammation

Trial Details

NCT Number	NCT07705737
Lead Sponsor	Connect Biopharm LLC
Conditions	Asthma Acute, COPD Exacerbation Acute
Enrollment	40 participants
Start Date	2026-07-30
Primary Completion	2026-12 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-15